Skip to main content
ANIMALCARE GROUP PLC logo

ANIMALCARE GROUP PLC — Investor Relations & Filings

Ticker · ANCR ISIN · GB0032350695 LEI · 213800A7XPQ528RMCC72 IL Manufacturing
Open in API
Filings indexed 294 across all filing types
Latest filing 2024-05-15 Declaration of Voting R…
Country GB United Kingdom
Listing IL ANCR

About ANIMALCARE GROUP PLC

https://www.animalcaregroup.com/

Animalcare Group PLC is an international veterinary sales and marketing organization focused on improving animal health and wellbeing. The company develops, sources, and commercializes a range of veterinary pharmaceutical products and services designed to support the veterinary profession. Its growth strategy centers on bringing innovative products to market through a combination of its internal development pipeline, strategic partnerships, acquisitions, and the in-licensing of early and late-stage products. The company maintains a direct commercial presence in several European countries and exports to numerous markets globally.

Recent filings

Filing Released Lang Actions
Exercise of Options and Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is identified by the 'RNS Number' header and explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' The content announces the exercise of options, the subsequent issuance of new ordinary shares, and the resulting change in Total Voting Rights. This type of mandatory, short-form announcement disseminated via the London Stock Exchange's news service (RNS) fits best under the general 'Regulatory Filings' category, as it is not a specific financial report (like 10-K or IR), a management change (MANG), or a director's dealing (DIRS), but rather a required disclosure impacting the share capital structure.
2024-05-15 English
Grant of options and PDMR Dealing
Remuneration Information Classification · 99% confidence The document is an official announcement from Animalcare Group PLC, identified by the RNS Number and the header structure typical of regulatory news services. The content explicitly details the 'Grant of options and PDMR Dealing' for executive directors and senior management, including specific transaction details (award of nil-cost options) and compliance references to Article 19 of the Market Abuse Regulation (MAR). This type of filing, reporting personal share transactions by directors and executives, directly corresponds to the definition of Director's Dealing (DIRS). Although it is distributed via RNS, the specific content dictates the DIRS classification over the general RNS fallback.
2024-04-25 English
Sale of equity in STEM Animal Health Inc.
M&A Activity Classification · 99% confidence The document is identified by the header 'RNS Number : 3266K' and contains a formal announcement dated '11 April 2024' regarding a significant corporate transaction: the 'Sale of equity in STEM Animal Health Inc.' and an 'Exclusive Licence and Distribution Agreement'. This type of material, which details corporate actions, agreements, and strategic changes, is typically disseminated via regulatory news services. Since it is a specific corporate announcement that doesn't fit neatly into the defined categories like 10-K (Annual Report), ER (Earnings Release), or CAP (Financing Update), the most appropriate general regulatory filing category is RNS (Regulatory Filings). The document length is relatively short (4784 chars) and it is a direct announcement, not a detailed report itself.
2024-04-11 English
Investor presentation via Investor Meet Company
Report Publication Announcement Classification · 99% confidence The document is a short announcement (3032 characters) released via RNS (London Stock Exchange news service). The core content announces that the CEO and CFO will provide a live presentation following the publication of the Group's full-year results via 'Investor Meet Company' on a future date (April 15, 2024). This is not the full results document itself (like an ER or 10-K), but rather an announcement about the timing and logistics of an upcoming investor event/presentation related to those results. This fits the definition of a Report Publication Announcement (RPA) because it announces the publication/presentation of other material (the results and the subsequent presentation) and provides details on how to access the presentation, fitting the 'Menu vs Meal' rule for short announcements.
2024-04-09 English
Preliminary Unaudited Full Year Results 2023
Earnings Release Classification · 100% confidence The document explicitly states it contains "Preliminary Unaudited Results for the year ended 31 December 2023" and provides detailed financial highlights (Revenues, EBITDA, Profit before tax, EPS, Net debt, Dividend proposal) and strategic highlights for the full year. This structure is characteristic of a comprehensive annual financial report, although it is labeled 'Preliminary'. Since the document is very long (over 111,000 characters) and contains the full narrative review from the Chair and CEO, it is the report itself, not just an announcement of the report. The closest fit among the provided codes for a full annual financial performance review is the Annual Report (10-K). However, since this is a preliminary result announcement for a UK company (indicated by RNS number and AIM listing), it is more accurately classified as a comprehensive Interim/Quarterly Report (IR) if it were quarterly, but for annual results, 10-K is the standard US equivalent. Given the context of providing full year results and detailed financial tables/narratives, and lacking a specific 'Preliminary Annual Report' code, the most appropriate classification for a comprehensive annual financial disclosure is 10-K, as it covers the full year's performance. If the document were solely the announcement of these results without the full text, it would be ER or RPA. Since the full text is present, it functions as the Annual Report content. The mention of the AGM date (June 20, 2024) and Chair succession suggests it is released around the time of the Annual Report cycle. FY 2023
2024-04-09 English
Disposal of Identicare Ltd
M&A Activity Classification · 99% confidence The document is an official announcement disseminated via RNS (Regulatory News Service), indicated by the 'RNS Number' header and the concluding boilerplate text referencing RNS and the London Stock Exchange. The content details a specific corporate action: the disposal of a subsidiary (Identicare Ltd) for cash consideration, which strengthens the balance sheet and relates to capital allocation strategy. This type of material, non-financial event announcement that is not a standard periodic report (like 10-K or IR) or a specific transaction type (like DIRS or DIV), falls best under the general 'Regulatory Filings' category, which serves as the fallback for miscellaneous regulatory announcements not covered by more specific codes. Although it relates to capital structure, it is an announcement of a transaction/disposal, not a direct financing activity (CAP) or share repurchase (POS). Given the RNS source and the nature of the announcement, RNS is the most appropriate classification.
2024-02-28 English

Browse filings by year

29 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.